Although mutations in SRSF2 are frequently observed in individuals with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML) (72, 73, 74, 75, 76), SRSF2 has not been commonly associated with human neurodegenerative disease. This evidence concerns the gene SRSF2 and neurodegenerative disease.